OPPENHEIMER ASSET MANAGEMENT INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$510,732
+10.5%
12,592
-9.8%
0.01%0.0%
Q3 2022$462,000
-9.2%
13,964
-3.4%
0.01%
-11.1%
Q2 2022$509,000
-25.5%
14,449
-2.7%
0.01%
-10.0%
Q1 2022$683,000
-31.1%
14,845
-0.8%
0.01%
-23.1%
Q4 2021$992,000
+2.1%
14,960
-3.9%
0.01%
-7.1%
Q3 2021$972,000
-27.8%
15,563
-4.3%
0.01%
-26.3%
Q2 2021$1,346,000
+22.6%
16,256
-1.9%
0.02%
+11.8%
Q1 2021$1,098,000
-16.1%
16,564
-2.8%
0.02%
-22.7%
Q4 2020$1,308,000
+74.9%
17,048
-1.8%
0.02%
+46.7%
Q3 2020$748,000
-0.9%
17,362
-0.6%
0.02%
-6.2%
Q2 2020$755,000
+52.2%
17,471
+1.2%
0.02%
+33.3%
Q1 2020$496,000
-55.6%
17,256
-1.9%
0.01%
-50.0%
Q4 2019$1,116,000
+120.1%
17,599
-2.1%
0.02%
+118.2%
Q3 2019$507,000
+4.3%
17,981
-1.9%
0.01%0.0%
Q2 2019$486,000
+23.0%
18,323
-14.7%
0.01%
+22.2%
Q1 2019$395,000
+18.3%
21,481
-20.1%
0.01%
+12.5%
Q4 2018$334,00026,8720.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders